Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
SMPX has been implicated in X-linked nonsyndromic sensorineural hearing loss (DFNX4, X-linked Hearing Loss 4). Pathogenic variants, notably truncating and splice-site changes, lead to progressive auditory impairment predominantly in male hemizygotes (PMID:21893181).
In a large Dutch DFNX4 pedigree, linkage analysis and sequencing identified a truncating variant p.Glu72Ter in SMPX segregating with hearing loss in 25 carriers, including 10 hemizygous males and 14 heterozygous females, with one 25-year-old female exception (PMID:21893181). A Han Chinese family harbored a donor splice-site variant c.132+1G>A (p.Met45GlyfsTer16) in the proband, with two obligate female carriers, indicating X-linked recessive inheritance (PMID:31478598).
Affected males exhibited early onset between 2–10 years (mean 3.3 years), rapid progression in the first two decades, and high-frequency deterioration, while female carriers showed later onset (3–48 years, mean 26.4 years), milder thresholds, and greater interaural variability (PMID:21893181). Longitudinal regression confirmed significant progression in multiple individuals of both sexes.
Functional assays of the c.132+1G>A variant demonstrated aberrant splicing with four alternative transcripts, resulting in a frameshift and premature termination codon that triggered nonsense-mediated mRNA decay, consistent with a loss-of-function mechanism (PMID:31478598).
No conflicting evidence has been described; in silico analyses predict additional SMPX missense variants as deleterious, supporting structural impact on protein stability.
Together, segregation in two unrelated pedigrees, concordant audiometric profiles, and functional validation solidify a strong gene-disease relationship. SMPX screening is recommended for males with familial sensorineural hearing loss and for female carriers in at-risk lineages.
Gene–Disease AssociationStrong25 carriers segregating in a Dutch family ([PMID:21893181]) and an additional Han Chinese pedigree ([PMID:31478598]) with concordant phenotypes and inheritance. Genetic EvidenceStrongTruncating and splice‐site variants observed in two unrelated families totaling 26 affected carriers, meeting the genetic evidence cap. Functional EvidenceModerateSplice‐site variant c.132+1G>A produces aberrant transcripts and triggers NMD consistent with loss‐of‐function ([PMID:31478598]). |